Treatment of chronic typhoid carriers with ampicillin.
D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000707:Anaphylaxis; D001219:Aspartate Aminotransferases / Q000097:blood; D001806:Blood Urea Nitrogen; D002353:Carrier State / Q000188:drug therapy*; D002908:Chronic Disease; D003470:Culture Media; D003967:Diarrhea / Q000139:chemically induced; D004197:Disease Reservoirs; D005243:Feces / Q000382:microbiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012485:Salmonella typhi / Q000302:isolation & purification; D013997:Time Factors; D014435:Typhoid Fever / Q000188:drug therapy*; D014581:Urticaria / Q000139:chemically induced
D003470:Culture Media; D000667:Ampicillin; D001219:Aspartate Aminotransferases